CRA was retained by the Plaintiff in a trade secrets litigation. CRA’s expert evaluated possible settlement options related to an alleged theft of trade secrets. The team calculated the expected present value (EPV) for the upfront and development milestones of the asset. The EPV model was used to aid counsel in settlement discussions.
Beyond the single asset: The rise of combination and synergistic innovation in neurology drug development
Introduction Historically, drug development within the neurology space has been characterized by the search for individual therapies that can arrest complex...